Aspen

Aspen produces drugs for anesthesia and sedation, gynecological diseases and cancer drugs. One of the company's main focuses is the development of anticoagulant drugs and becoming a leader in anticoagulant treatments in Europe.

The company first entered the European market in 2009 and has grown rapidly since 2014. Aspen is committed to offering high-quality medicines at competitive prices.

Corporate website

www.aspenpharma.eu

Stefan Robert Gissurarson

Business Manager - Sales Team 2

Pharmaceutical field

stefan.robert@icepharma.is

Phone 540 8056

GSM   821 8056